This inventor holds 3 USPTO granted patents. Top assignee: Karus Therapeutics Limited. Active years: 2018-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018-2020
Title: Alexander R L Cecil: Innovator in Pharmaceutical Compounds
Introduction
Alexander R L Cecil is a notable inventor based in Oxfordshire, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that serve as inhibitors for various therapeutic targets. With a total of 3 patents to his name, Cecil's work is recognized for its potential impact on medical treatments.
Latest Patents
Cecil's latest patents include innovative compounds that have promising applications in therapy. One of his notable inventions is related to histone deacetylase inhibitors. This invention presents a compound of a specific formula or a pharmaceutically acceptable salt thereof, which is useful as an HDAC inhibitor. Another significant patent involves tricyclic heterocyclic compounds that act as phosphoinositide 3-kinase inhibitors. This invention also describes a compound of a particular formula or a pharmaceutically acceptable salt and/or stereoisomers thereof, highlighting its therapeutic utility.
Career Highlights
Cecil is currently associated with Karus Therapeutics Limited, where he continues to advance his research and development efforts. His work focuses on creating innovative solutions that address unmet medical needs. His expertise in pharmaceutical compounds has positioned him as a valuable contributor to the field.
Collaborations
Cecil has collaborated with several professionals in his field, including Stephen Joseph Shuttleworth and Franck Alexandre Silva. These collaborations have likely enhanced the scope and impact of his research endeavors.
Conclusion
Alexander R L Cecil is a distinguished inventor whose work in pharmaceutical compounds demonstrates his commitment to advancing medical science. His patents reflect a dedication to developing innovative therapies that could benefit patients worldwide.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile